Skip to main content
BoomMag: Readers and Fans
Advertise With Us

WLT Report WLT Report

Advertise With Us
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

CDC Issues Marburg Virus Emergency Alert!

The U.S. Centers for Disease Control and Prevention (CDC) on Thursday issued an emergency health alert about two confirmed outbreaks of Marburg virus disease (MVD).

From the CDC:

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to inform clinicians and public health departments in the United States about two confirmed outbreaks of Marburg virus disease (MVD)—one in Equatorial Guinea and one in Tanzania. Currently, there is no evidence to suggest that these two outbreaks are related; most experts agree that these represent two independent animal-to-human spillover events. To date, no confirmed cases of MVD related to these outbreaks have been reported in the United States or other countries outside Equatorial Guinea and Tanzania. This Health Advisory provides information about these outbreaks to increase awareness of the risk of imported cases in the United States. It also summarizes CDC’s recommendations for case identification, testing, and clinical laboratory biosafety considerations in the United States.

Background
Marburg virus disease is a rare but highly fatal viral hemorrhagic fever caused by two zoonotic viruses, Marburg virus and Ravn virus, that are closely related to ebolaviruses within family Filoviridae. In February and March 2023, two distinct outbreaks of Marburg virus were reported in Equatorial Guinea and Tanzania. These outbreaks mark the first time that Marburg virus has been identified in either Equatorial Guinea or Tanzania, though the virus has been identified previously in neighboring countries and the reservoir, the Egyptian fruit bat, is known to be present in both countries. Available information suggests that these outbreaks may have originated separately in each country. To date, there is no evidence that these two outbreaks are epidemiologically linked. Viral genetic sequencing from Tanzania is in process; these results, along with sequence data available from Equatorial Guinea, will further inform whether the outbreaks emerged separately through distinct animal-to-human spillover events.

A person with MVD is not contagious until symptoms appear. Symptoms may include fever, headache, muscle and joint pain, fatigue, loss of appetite, gastrointestinal symptoms, or unexplained bleeding. Marburg virus is spread through contact (through broken skin or mucous membranes) with the blood or other body fluids (including urine, saliva, sweat, feces, vomit, breast milk, amniotic fluid, or semen) of a person who is sick with or has died from MVD, with the body fluids of infected animals, or with needles or other fomites that are contaminated with the virus. Marburg virus is not spread through airborne transmission.

There is currently no Food and Drug Administration (FDA)-approved vaccine or treatment for MVD. In the absence of early diagnosis and appropriate supportive care, MVD has a high mortality rate of 23%–90%. With early intensive supportive care and fluid replacement, mortality rates may be lower.

MVD Outbreak in Equatorial Guinea
On February 7, 2023, the Ministry of Health and Social Welfare of Equatorial Guinea reported a cluster of deaths suspected to be caused by a viral hemorrhagic fever. The deaths occurred in early January among people in two villages in the district of Nsok-Nsomo, in the eastern province of Kié-Ntem, Río Muni Region.

On February 12, 2023, clinical samples were collected from known contacts of the decedents and sent to the Institute Pasteur in Dakar, Senegal, where one sample was confirmed positive for Marburg virus by real-time polymerase chain reaction (RT-PCR). This index (first confirmed) patient presented with fever, vomiting, bloody diarrhea, and convulsions and died the same day. This patient appears to be epidemiologically linked to four deceased community members from one of the affected villages in Nsok-Nsomo district.

On March 13, 2023, two additional samples collected from people in Kié-Ntem province tested positive for Marburg virus by RT-PCR performed at a CDC-supported field laboratory at the Regional Hospital of Ebibeyin. As of April 5, 2023, 14 laboratory-confirmed MVD cases have been identified from five districts across four provinces in Equatorial Guinea. Ten of these cases were fatal. There are no known epidemiologic links between patients in one province, Centre Sur. This, taken together with the wide geographic spread of the outbreak within the country, suggests that there may be undetected community spread of the virus in the country. All suspect cases in nearby surrounding countries have been confirmed negative to date.

MVD Outbreak in Tanzania
On March 21, 2023, the Ministry of Health of Tanzania announced an MVD outbreak. The announcement followed the identification of Marburg virus by RT-PCR in clinical samples collected from patients in several villages in the northwest Kagera region. As of April 5, 2023, 8 laboratory-confirmed MVD cases have been reported. Five of these infections were fatal. Based on currently available information, all these individuals with MVD are from Kagera Region in Tanzania and appear to be epidemiologically linked.

Unsurprisingly, researchers are developing ‘vaccines’ for Marburg virus.

Researchers at the NIAID are developing an experimental Marburg virus ‘vaccine’.

Per the NIH:

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, could someday be an important tool to respond to Marburg virus outbreaks.

This first-in-human, Phase 1 study tested an experimental MARV vaccine candidate, known as cAd3-Marburg, which was developed at NIAID’s Vaccine Research Center (VRC). This vaccine uses a modified chimpanzee adenovirus called cAd3, which can no longer replicate or infect cells, and displays a glycoprotein found on the surface of MARV to induce immune responses against the virus. The cAd3 vaccine platform demonstrated a good safety profile in prior clinical trials when used in investigational Ebola virus and Sudan virus vaccines developed by the VRC.

MARV, a filovirus in the same family as Ebola virus, causes a rapidly progressive febrile illness that leads to shock and death in a large proportion of infected individuals. Many scientists think that MARV disease outbreaks in humans begin by when the virus makes the jump from its primary animal host, which is likely to be certain chronically infected bats in sub-Saharan Africa. The symptoms of MARV disease are akin to those seen with Ebola virus disease and can include fever, headache, chills, rash, abdominal pain, vomiting, and diarrhea. As the disease progresses, patients may suffer from multiple organ dysfunction, delirium, and significant bleeding from the gastrointestinal tract or other sites that may result in death. No approved vaccines or specific therapies are available for MARV disease, aside from supportive care. While some experimental vaccines have previously been tested, none have proven to be both highly effective and to provide durable protection. In areas of Africa where a vaccine for Marburg is most needed, a single-dose vaccine that could protect recipients over a long period of time would be a crucial part of quelling outbreaks.

In this study, 40 healthy adult volunteers were enrolled at the Walter Reed Army Institute of Research Clinical Trials Center in Silver Spring, Maryland. They received a single dose of either a low dose of the vaccine (1×1010 particle units) or a higher dose (1×1011 particle units). For safety, the volunteers were enrolled in a dose-escalation plan. Three participants received the lower dose. Then, when they did not exhibit severe adverse reactions after the first seven days, the trial proceeded to enroll the remaining 17 volunteers. The same procedure was also used for the higher dose group. Volunteers were monitored for adverse reactions to the investigational vaccine and evaluated at regular intervals for 48 weeks to track their immune responses.

We’ve actually been warning you about this for almost a year now…

That’s why you trust WLTR, because we are well-researched and we bring you the news the MSM doesn’t want you to know.

And we bring it to you AHEAD OF TIME often.

Here’s what we covered most recently, about a month ago:

BREAKING: Nine Dead In Marburg Virus Outbreak!

Here we go…

Ready for the next Planned-Demic?

Bill Gates keeps telling us a bigger one is coming.

Did it just hit?

I’ve been warning you about the “Marburg Virus” for several months now.

And what suddenly hit the news this morning?

A new outbreak of the Marburg Virus has NINE people dead and counting.

This is just breaking right now.

Details:

InsiderPaper reports:

Nine people have died in Equatorial Guinea from the Marburg virus, which causes a hemorrhagic fever nearly as deadly as Ebola, the health ministry said Monday, and put a province in quarantine.

The government had announced last week that it was investigating the cause of suspect cases of hemorrhagic fever in the rural eastern region near the borders of Gabon and Cameroon.

And from the WHO:

https://twitter.com/WHOAFRO/status/1625198981989994508

WHO Africa:

Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried out following the deaths of at least nine people in the country’s western Kie Ntem Province turned out positive for the viral haemorrhagic fever.

Equatorial Guinean health authorities sent samples to the Institut Pasteur reference laboratory in Senegal with support from World Health Organization (WHO) to determine the cause of the disease after an alert by a district health official on 7 February. Of the eight samples tested at Institut Pasteur, one turned out positive for the virus. So far nine deaths and 16 suspected cases with symptoms including fever, fatigue and blood-stained vomit and diarrhoea have been reported.

Further investigations are ongoing. Advance teams have been deployed in the affected districts to trace contacts, isolate and provide medical care to people showing symptoms of the disease. Efforts are also underway to rapidly mount emergency response, with WHO deploying health emergency experts in epidemiology, case management, infection prevention, laboratory and risk communication to support the national response efforts and secure community collaboration in the outbreak control.

WHO is also facilitating the shipment of laboratory glove tents for sample testing as well as one viral haemorrhagic fever kit that includes personal protective equipment that can be used by 500 health workers.

“Marburg is highly infectious. Thanks to the rapid and decisive action by the Equatorial Guinean authorities in confirming the disease, emergency response can get to full steam quickly so that we save lives and halt the virus as soon as possible,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

Marburg virus disease is a highly virulent disease that causes haemorrhagic fever, with a fatality ratio of up to 88%. It is in the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly, with high fever, severe headache and severe malaise. Many patients develop severe haemorrhagic symptoms within seven days. The virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials.

There are no vaccines or antiviral treatments approved to treat the virus. However, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improves survival. A range of potential treatments, including blood products, immune therapies and drug therapies, as well as candidate vaccines with phase 1 data are being evaluated.

This next tweet is a joke, but perhaps has a lot of truth in it…

How do we know what’s in all these balloons being shot down?

Oh I’m 100% in favor of shooting them down, but truth is we don’t know:

https://twitter.com/StonedPattio/status/1622017053522804736

Many may remember I warned you about the Marburg Virus back in December:

Have You Heard About The “Marburg Virus”?

Noah here and I am one of the first to cover this…

Just remember that when you hear it plastered all over your news later on.

We bring you the truth here and we often bring it to you early.

Have you heard of the “Marburg Virus”?

It’s very likely to become COVID 2.0.

Of course, they won’t call it that.

But you do know they’ve been planning for the NEXT pandemic, right?

Planning….

Causing….

The words are almost indistinguishable at this point.

I actually thank a reader for bringing this to my attention, and how awesome is that?

I always say we’re better together!

I can’t possibly stay up on every single news story, so I love it when you all help me out.

So let’s talk Marburg Virus….

And let’s start here:

Here is Science.org….Science Magazine with their December 2022 issue:

Look at that…Mitigating the Marburg Virus!

They are laying the groundwork….

Didn’t COVID break in January?

We getting ready for a repeat?

Full text if that’s hard to read:

ONLINE COVER: Mitigating Marburg Virus. This image shows a transmission electron micrograph of Marburg virus (MARV) particles. MARV is a filovirus that causes severe, often lethal hemorrhagic fever disease in humans and nonhuman primates and is a Priority Pathogen for vaccine development. Here, Hunegnaw et al. evaluated the efficacy of a chimpanzee adenovirus 3 (ChAd3)-MARV vaccine in nonhuman primates. The authors found that the vaccine, when administered as a single dose, conferred protection against lethal MARV challenge from as early as 7 days after vaccination to as late as 1 year after vaccination, with antigen-specific antibodies serving as a correlate of protection. Together, these results support further clinical development of the ChAd3-MARV vaccine.

Credit: Science Source

Here’s more:

Here’s more from the Times of India (is this one set to break out from India this time instead of China?):

An outbreak of the deadly Marburg virus disease (MVD) has been reported in Ghana. Two cases have been reported in the southern Ashanti region of the West African nation. Reportedly, both the patients have died and 98 people have been put under quarantine.

As per the World Health Organisation (WHO), MVD is a severe, often fatal illness in humans with a fatality rate around 50%. Past outbreaks have seen severe fatalities. The WHO says the Marburg virus disease fatality rates have varied from 24% to 88% in the past. Research studies have claimed even a higher fatality rate; as per a recent research study, Marburg virus is one of the world’s most threatening diseases, causing severe haemorrhagic fever, with a case fatality rate of 90% and lack of antiviral drugs makes dealing with this disease even difficult.

Fruit bats of the Pteropodidae family known as Rousettus aegyptiacus are the natural hosts of the virus. This virus belongs to the same family, Filoviridae family (filovirus), as the Ebola virus. The deadly virus is transmitted from these bats to people and later spread among human beings.

Just like COVID, this viral disease also needs community engagement to create awareness and stop the spread.

The common signs which can indicate a Marburg viral attack are:

  • Fever
  • Severe headache
  • Severe discomfort, illness
  • Muscle aches
  • Pain
  • Diarrhea

As per the European Centre for Disease Prevention and Control (ECDC), the entire incubation period of the Marburg viral infection can be divided into three broad phases:

“The clinical course can be divided into three phases: the first generalised phase (days 1–4), early organ phase (days 5–13), followed by either a late organ or a convalescence phase (days 13+),” the ECDC says.

The ECDC says more than 50% of the patients experience gastrointestinal symptoms such as anorexia, abdominal discomfort, severe nausea, vomiting, and diarrhoea

Apart from the common signs, there are certain critical symptoms of the viral attack which are seen in phases.

The incubation period varies from 2 to 21 days and on the third day mostly, the patient is likely to experience symptoms like severe watery diarrhoea, abdominal pain and cramping, nausea and vomiting. During this time, people have ghost-like appearance with deep-set eyes, expressionless faces and extreme weakness.

Many people develop hemorrhagic manifestations between 5 and 7 days. Due to bleeding from the nose, gums, and vagina traces of fresh blood are seen in vomit and faeces.

Inflammation of one or both testicles known as orchitis is also seen in individuals in the late phase of the disease which begins around the 15th day, the WHO has said.

Orchitis usually occurs following a bacterial or viral infection. Mumps virus are also known to cause orchitis.

In fatal cases, death occurs mostly between 8 and 9 days after the onset of the symptoms and follows after severe blood loss and shock.

Severe illness and bleeding are the fatal signs of this viral infection.

Among humans it is transmitted through blood, bodily secretions, through direct contact with the patient like using bedding or sharing clothing. Health workers are at higher risk of contracting the infection.

Humans contract this virus from the fruit bats.

Based on my research, it appears the Marburg Virus may be related to “Nose-bleed Fever”.

That’s very interesting to me….

Have you experienced more nosebleeds than normal recently?

I actually have.

I’ve NEVER had a problem with nosebleeds my entire life, but I’ve suddenly had a decent amount this year.

It’s very strange and concerning.

And now perhaps I know why.

Is this virus already out in the open?

Luckily, I have no other symptoms than the nosebleed, thankfully.

Probably because I take ESS60 and Vitamin D and the Zelenko regimen.

Might be keeping me safe!

Here’s more:

The NY Post had more:

“Nose-bleed fever” is as gruesome as it sounds.

More technically called Crimean-Congo hemorrhagic fever, the tick-borne virus has been detected in some 120 people in Iraq since January — including 18 who have died from the disease — health officials have warned, fearing an escalating spread.

The onset of illness causes rapid and severe internal and external bleeding in infected patients, including through the nose, hence its nickname “nose-bleed fever.” Though the virus is hosted in ticks, most individuals pick it up by coming in contact with infected animal blood — usually occurring among those who work with livestock and in slaughterhouses.

The virus is not novel, but it is rare — and apparently spreading at an unprecedented rate throughout Iraq.

Between 10 and 40 percent of cases will die from the disease. Aside from profuse bleeding and potential death, early symptoms include fever, body aches, dizziness, neck pain, headache and sore eyes. Nausea, vomiting, diarrhea, sore throat and brain fog have also been observed in infected patients, according to the World Health Organization.

Iraqi Prime Minister Mustafa al-Kadhimi also allocated 1 billion dinars to spraying livestock farms with pesticides to rid them of host ticks, especially in the southern province of Dhi Qar — the current epicenter of the outbreak where more than half of recent cases have originated. Meanwhile, veterinary clinics have also been issued pesticides, according to Iraq’s agricultural ministry, which urges the country’s citizens to purchase meat only from licensed suppliers.

The rise in cases of nose-bleed fever may be blamed, in part, on the nation’s failure to see through pesticide-spraying campaigns in 2020 and 2021 due to the COVID-19 pandemic, according to Ahmed Zouiten, the WHO’s representative in Iraq.

Here’s what CNN had to say:

There is little risk of the deadly nose-bleed fever, which was recorded in Iraq, entering the country, according to an adviser of the Department of Health (DOH).

Dr. Edsel Salvaña allayed fears in a media briefing on Friday after the World Health Organization (WHO) reported that the disease killed 27 people in Iraq from May 22 to June 1.

This death toll is out of over 200 suspected and confirmed cases during the period.

Salvaña explained that the nose-bleed fever, also known as Crimean-Congo Hemorrhagic Fever (CCHF), is tick-borne. There is no case of the disease in the country, he said.

“Wala naman tayong ganyang klaseng ticks dito [We don’t have those kinds of ticks here]…so the risk sa atin overall is very small,” the member of the DOH Technical Advisory Group told reporters.

“We will continue to monitor, but you know, chances are if somebody presents that way, it’s probably dengue dito sa Pilipinas [here in the Philippines]. Kumbaga may mga niche niche ‘yang mga hemorrhagic fevers na ‘yan [We can say those hemorrhagic fevers have niches],” he added.

According to WHO, the CCHF virus causes severe viral fever outbreaks, with a case fatality rate of 10% to 40%.

Does Dr. Zelenko have the solution?

Check this out:

Dr. Zelenko: You Have To Get The Zinc To The Virus, And The Magic Ingredient Is…

Winter is coming and you heard it here first: they’re going to try and “spark up” COVID again.

That’s right.

Joe Biden is already threatening ANOTHER “dark winter”.

So be prepared…

And supercharge your immune system!

Hey, what’s the worst that could happen, you stave off cold and flu season?

Sounds good to me.

Dr. Zelenko famously said: You Have To Get The Zinc To The Virus, And The Magic Ingredient Is…Quercetin!

The magic ingredient to open the door of the cell so the killer-bullet (Zinc) can attack the virus is Quercetin.

Also Ivermectin.

Also Hydroxycholoroquine.

They all work.

But Quercetin is readily available and does not need a doctor’s prescription, so Dr. Zelenko used it to formulate his perfect  and proprietary “Z-Stack” blend.

And millions are happy he did.

CURRENT STATUS OF Z-STACK: BACK IN STOCK!

WND explains more:

When Upstate New York physician Dr. Vladimir “Zev” Zelenko drew the attention of President Trump back in the spring of 2020 with a simple protocol of cheap, proven, widely available drugs for COVID-19 that included hydroxychloroquine, he had successfully treated more more than 350 patients, with only one needing hospitalization.

Nearly two years later, amid continued government and media suppression of early treatments, Zelenko told WND in a video interview that he and his team have administered what is now know as the Zelenko Protocol to more than 7,000 COVID patients, with only three deaths.

Moreover, his cocktail of hydroxychloroquine, the popular antibiotic azithromycin and zinc sulfate – along with other combinations of drugs, such as ivermectin – has been adopted by more than 1,000 physicians around the world, along with America’s Frontline Doctors.

Among them are Dr. George Fareed, a former professor of virology at Harvard Medical School, and Dr. Brian Tyson. Since April 2020, they collectively have treated more than 7,000 COVID-19 patients in California’s Imperial Valley, with only a few deaths. And no patient died who was treated within the first seven days.

Zelenko has explained that the key virus killer is zinc, which has a known antiviral effect, and it’s drugs like hydroxychloroquine, ivermectin and quercetin that “open the door to the cell and let the zinc in.”

Since the spring of 2020, he also has been using blood thinners, steroids, monoclonal antibodies and other treatments, but he said he has never changed his messaging since making his appeal to President Trump.

And now he has developed an over-the-counter formulation to treat COVID-19 called Z-Stack that contains zinc, quercetin, vitamin D and vitamin C.

The objective, he said, always has been to prevent a COVID-19 infection from progressing to the catastrophic lung injury called acute respiratory distress syndrome, or ARDS, which requires hospitalization and often a ventilator. He found early on that more than 80% of the people with COVID who were put on a respirator were dying. His protocols don’t treat ARDS, but they can keep people from ever developing it.

His approach has been to identify high-risk COVID patients, start treatment immediately with an antiviral and anti-inflammatory combination and tailor the treatment to each patient.

In the video interview with WND, Zelenko tells the story of how he appealed to President Trump in a video and 16 hours later received a phone call from Mark Meadows, who was preparing to become the White House chief of staff.

“You can’t make this stuff up. I wouldn’t believe it, but it happened to me,” he said.

That’s not all.

Dr. Zelenko has also explained how we could have ended this pandemic LONG ago…

In this writer’s opinion, it’s a crime against humanity we weren’t allowed to.

Also from WND:

Fauci was asked in a March 2020 interview with Philadelphia talk-host Chris Stigall whether or not he would prescribe hydroxychloroquine or chloroquine as a treatment for COVID-19.

“Yeah, of course, particularly if people have no other option. You want to give them hope,” said Fauci, the director the National Institute of Allergy and Infectious Diseases. “In fact, for physicians in this country, these drugs are approved drugs for other reasons. They’re anti-malaria drugs and they’re drugs against certain autoimmune diseases, like lupus.”

WND asked Zelenko what he thinks has happened in the meantime.

“Well, in the meantime 850,000 Americans are dead, and we could have prevented probably 730,000 of them from even going to the hospital and ended this pandemic globally,” he replied, alluding to the finding of his paper. “That’s what happened.”

America’s Got Talent Contestant Skilyr Hicks Dead At 23
Prominent medical scientists such as epidemiologist Dr. Harvey Risch of the Yale School of Medicine also have concluded that many lives could have been saved with early treatment.

Eventually, Fauci was regularly contradicting the president regarding hydroxychloroquine. And the FDA, in June 2020, removed emergency use authorization for the distribution of hydroxychloroquine from Strategic National Stockpile, based on “new information.” But the decision largely relied on a study published by The Lancet that was embarrassingly retracted by its authors because of faulty data, as WND reported at the time. Later that year, Risch, Dr. George Fareed and Dr. Peter McCullough testified to the U.S. Senate that hydroxychloroquine was being misrepresented in studies and used as a political weapon.

Zelenko pointed to a published paper posted on the National Institutes of Health website in 2005 showing the antiviral properties of chloroquine against SARS is on the level of a vaccine. Hydroxychloroquine is a less toxic analogue of chloroquine. An October 2020 paper posted on the NIH website that reviewed published studies found hydroxychloroquine “is effective, and consistently so when provided early, for COVID-19.” A real-time analysis, which to date has assessed 283 peer-reviewed studies, has come to the same conclusion.

“[But] the NIH today recommends not treating COVID unless you’re in the hospital with lung damage,” Zelenko said. “Really?”

I have the full interview for you right here.

Don’t miss this.

From Rumble:

And don’t miss this…

The famous Z-Stack formula is now in gummies specially formulated for kids!

Available now:

How Dr. Zelenko Bypassed The “Hydroxychloroquine (HCQ) Ban” to Beat COVID-19

Don't think a second Planned-Demic is coming?

Then you're not paying attention to what Bill Gates is doing:

Planned-Demic 2.0: While You Weren't Looking, Bill Gates Just Simulated ANOTHER Pandemic

Are the globalists planning the next 'pandemic' before our eyes?

The Johns Hopkins Center for Health Security, World Health Organization, and Bill & Melinda Gates Foundation conducted a global pandemic simulation for a pathogen deadlier than SARS-CoV-2.

This global pandemic simulation is named "Catastrophic Contagion."

Unlike COVID-19, this plandemic disproportionately affected children and young people.

Catastrophic Contagion falls almost precisely three years after the globalists' last simulation (known infamously as Event 201) of a coronavirus escaping in October 2019.

This latest plandemic tabletop exercise occurred via a desktop simulation of a new Enterovirus originating near Brazil.

The virus simulated has a higher fatality rate than COVID-19.

Bill Gates and senior public health officials from Angola, Germany, India, Liberia, Nigeria and Rwanda moderated discussions during the simulation.

The group conducted Catastrophic Contagion in Brussels, Belgium on October 23, 2022.

During the exercise, the WHO's health advisory board addressed the fictional “Severe Epidemic Enterovirus Respiratory Syndrome."

Catastrophic Contagion Tabletop Exercise

*Image from Johns Hopkins Center for Health Security*

Via Johns Hopkins:

The Johns Hopkins Center for Health Security, in partnership with WHO and the Bill & Melinda Gates Foundation, conducted Catastrophic Contagion, a pandemic tabletop exercise at the Grand Challenges Annual Meeting in Brussels, Belgium, on October 23, 2022.

The extraordinary group of participants consisted of 10 current and former Health Ministers and senior public health officials from Senegal, Rwanda, Nigeria, Angola, Liberia, Singapore, India, Germany, as well as Bill Gates, co-chair of the Bill & Melinda Gates Foundation.

The exercise simulated a series of WHO emergency health advisory board meetings addressing a fictional pandemic set in the near future. Participants grappled with how to respond to an epidemic located in one part of the world that then spread rapidly, becoming a pandemic with a higher fatality rate than COVID-19 and disproportionately affecting children and young people.

Participants were challenged to make urgent policy decisions with limited information in the face of uncertainty. Each problem and choice had serious health, economic, and social ramifications.

WATCH:

https://www.youtube.com/watch?v=Eya-mUFEhqc

Here's a Rumble backup courtesy of Chief Nerd:


, ,

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

log in

Forgot password?

reset password

Back to
log in
Leave a comment
Thanks for sharing!
Thanks for sharing!
We invite you to become a WLT Report insider. Sign up for our free email newsletter, and we'll make sure to keep you in the loop.